News - Latest

48 news items

Enter search criteria

Fill in keyword(s) to narrow your search.

Period
Period
Sort by:
Subscribe to latest news
  1. Request to take over the pyridoxine hydrochloride marketing authorisation

    The company Pharmachemie B.V. has requested the Medicines Evaluation Board (MEB) to withdraw marketing authorisation for ...

    News item | 30-03-2020 | 17:00

  2. Changes to product information policy

    The Medicines Evaluation Board (MEB) recently revised a number of policy documents for pharmaceutical companies relating to the ...

    News item | 23-03-2020 | 12:00

  3. Coronavirus - MEB employees work from home

    Complying with the Dutch government guidelines regarding the coronavirus situation, MEB employees will be working from home as of ...

    News item | 13-03-2020 | 15:30

  4. Regulatory Science Magazine 10: Reduction, replacement and refinement of animal studies

    This week, the newest edition of the Regulatory Science Magazine was issued. This 10th edition of the online science magazine of ...

    News item | 10-03-2020 | 15:00

  5. Amended policy on DHPCs

    The Medicines Evaluation Board (MEB) has amended its policy on Direct Healthcare Professional Communications (DHPCs). This ...

    News item | 21-02-2020 | 12:00

  6. MEB confirms current legal status of supply ibuprofen 200 mg

    The Medicines Evaluation Board (MEB) has evaluated whether the recent European review of the adverse events on heart and blood ...

    News item | 03-08-2015 | 00:00

  7. Decision regarding the Brinzolamide objection

    The Medicines Evaluation Board (MEB) has made a decision regarding an objection by Alcon Laboratories (UK) Ltd.

    News item | 17-07-2015 | 10:30

  8. New Veterinary Medicinal Products Regulation and Medicated Feed Regulation have come into force

    News item | 28-01-0022 | 10:40